Overview
Ontex is a leading international provider of personal hygiene solutions, with expertise in baby care, feminine care, and adult care. Its innovative products are distributed in more than 110 countries through leading retailer brands, lifestyle brands and Ontex brands. The company sells branded products, such as Cremer, Helen Harper, Silhouette, Moviment, and Sapeka, and also manufactures products for partner retailers. It sells directly to consumers
...
Read More through retail markets, and to healthcare institutions like hospitals, nursing homes, health insurers, and local authorities. Founded in 1979 in Belgium by Paul Van Malderen, Ontex generates the majority of its revenue in the UK.
Read Less
Read More through retail markets, and to healthcare institutions like hospitals, nursing homes, health insurers, and local authorities. Founded in 1979 in Belgium by Paul Van Malderen, Ontex generates the majority of its revenue in the UK.
Read Less
Gustavo Calvo Paz
See more contacts
Management of Companies and Enterprises
,
Business Support Services
,
Fiber, Yarn, and Thread Mills
,
Basic Chemical Manufacturing
,
Holding companies, nec
See All Industries , Business services, nec , Textile goods, nec Industrial inorganic chemicals, nec
See Fewer Industries
See All Industries , Business services, nec , Textile goods, nec Industrial inorganic chemicals, nec
See Fewer Industries
?
?
Actual
$2.12 billion
Actual
3.67%
-70.4%
$2,360
?
?
BSE:ONTEX
Contacts
Get in Touch with 14 Principals*
-
Gustavo Calvo PazGeneral Manager
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue
$2.12 billion
USD
Modelled
1 USD = 0.8785 EUR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $246 | $183 | $32 |
| Net Investing Cash | -$116 | $135 | -$66 |
| Net Financing Cash | -$169 | -$353 | -$11 |
| Net Change in Cash | -$39 | -$34 | -$44 |
| Cash at Beginning of Period | $192 | $238 | $281 |
| Cash at End of Period | $141 | $192 | $238 |
| Capital Expenditure | -$128 | -$110 | -$71 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $65 | $111 | $170 |
| Accounts Receivable | $232 | $234 | $218 |
| Inventories | $333 | $288 | $301 |
| Other Current Assets | $383 | $421 | $815 |
| Asset Summary | |||
| Total Current Assets | $1,013 | $1,054 | $1,504 |
| Tangible Fixed Assets | $681 | $645 | $604 |
| Intangible Assets | $38 | $37 | $37 |
| Total Assets | $2,361 | $2,362 | $2,694 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $501 | $422 | $461 |
| Short-Term Debt | $38 | $140 | $143 |
| Other Current Liabilities | $299 | $295 | $431 |
| Liability Summary | |||
| Total Current Liabilities | $838 | $856 | $1,035 |
| Long-Term Debt | $657 | $655 | $901 |
| Other Long-Term Liabilities | $0 | -$0 | $ |
| Total Liabilities | $1,633 | $1,662 | $2,090 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $905 | $905 | $905 |
| Retained Earnings | -$353 | -$367 | -$412 |
| Equity Summary | |||
| Total Equity | $1,054 | $1,027 | $977 |
| Shares Outstanding | 81,087,174 | 81,147,789 | 81,076,718 |